Whole genome sequencing for investigation of age-related chronic disease in HANDLS participants

Where this opportunity stands

Every notice posted under solicitation 75N98026R00166AN in this department, oldest first.

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

• Note the winner and the end of the period of performance for the recompete.
• Follow the agency to see the next notice for this work.

Who won similar work

10 award notices on SAM.gov in the last 24 months. Matched by: Same agency (National Institutes of Health), same product/service code (PSC) Q301.

Single-winner award sizes (10): middle half $60K to $329K, median $136K; range $27K to $35.0M.

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

• Sep 26, 2025BAYLOR MIRACA GENETICS LABORATORIES LLC$232KQ--Clinical TestingNo listed company matched (Materiality N/A)
• Sep 25, 2025GREENWOOD GENETIC CENTER INC$49KQ--Genetic Testing with Greenwood Genetic Center IncNo listed company matched (Materiality N/A)
• Sep 23, 2025NEW YORK STEM CELL FOUNDATION INC$362KQ--iPSC Generation and Beta Cell DifferentiationNo listed company matched (Materiality N/A)
• Sep 22, 2025KAISER FOUNDATION HOSPITALS 1 KAISER PLAZA 22ND FLOOR Oakland CA 94612 USA$115KQ--Adherence with continuous positive airwayNo listed company matched (Materiality N/A)
• Sep 19, 2025ProteinTech Group Inc$90KCRO Services for Single-Cell Multiomics ProfilingNo listed company matched (Materiality N/A)
• Sep 19, 2025NORGEN BIOTEK CORP$157KQ--Small RNA characterization of urinary exosomesNo listed company matched (Materiality N/A)
• Jul 24, 2025ADVANCED CELL DIAGNOSTICS, INC.$27KQ--RNAscope In-House AssayMateriality: <0.01% of $TECH revenue (Low) SEC
• May 5, 2025HISTOSERV, INC$29KSignatures of aging outcomesNo listed company matched (Materiality N/A)
• Dec 31, 2024PSOMAGEN INC$533KLong read sequencing servicesNo listed company matched (Materiality N/A)
• Dec 2, 2024AZENTA US INC$35.0MQ--Childhood Cancer Data Initiative (CCDI)No listed company matched (Materiality N/A)

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.